2019 Form 10-K Financial Statement

#000165495421003243 Filed on March 25, 2021

View on sec.gov

Income Statement

Concept 2019
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.360M
YoY Change 51.28%
% of Gross Profit
Research & Development $1.970M
YoY Change 11.3%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $4.320M
YoY Change 29.73%
Operating Profit
YoY Change
Interest Expense $100.0K
YoY Change 0.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$4.220M
YoY Change 30.65%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$4.220M
YoY Change 30.65%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$405.0K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2019
SHORT-TERM ASSETS
Cash & Short-Term Investments $13.21M
YoY Change 91.73%
Cash & Equivalents $13.21M
Short-Term Investments
Other Short-Term Assets $20.00K
YoY Change -94.44%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $13.23M
YoY Change 82.48%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $120.0K
YoY Change 71.43%
Total Long-Term Assets $120.0K
YoY Change 71.43%
TOTAL ASSETS
Total Short-Term Assets $13.23M
Total Long-Term Assets $120.0K
Total Assets $13.35M
YoY Change 82.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $720.0K
YoY Change 80.0%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $720.0K
YoY Change 80.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $720.0K
Total Long-Term Liabilities $0.00
Total Liabilities $720.0K
YoY Change 80.0%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $12.63M
YoY Change
Total Liabilities & Shareholders Equity $13.35M
YoY Change 82.38%

Cashflow Statement

Concept 2019
OPERATING ACTIVITIES
Net Income -$4.220M
YoY Change 30.65%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$3.020M
YoY Change 12.69%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 9.350M
YoY Change -4552.38%
NET CHANGE
Cash From Operating Activities -3.020M
Cash From Investing Activities
Cash From Financing Activities 9.350M
Net Change In Cash 6.330M
YoY Change -319.03%
FREE CASH FLOW
Cash From Operating Activities -$3.020M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
63282 USD
CY2019Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
13083536 USD
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
3243 shares
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18361 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD

Files In Submission

Name View Source Status
0001654954-21-003243-index-headers.html Edgar Link pending
0001654954-21-003243-index.html Edgar Link pending
0001654954-21-003243.txt Edgar Link pending
0001654954-21-003243-xbrl.zip Edgar Link pending
a10-k12312020.htm Edgar Link pending
a10weeklycardiacechoes.jpg Edgar Link pending
a11camsicardiaccontractil.jpg Edgar Link pending
a12pancreaticovarian.jpg Edgar Link pending
a1ourproductpipeline.jpg Edgar Link pending
a2incidenceofsom.jpg Edgar Link pending
a3medianduration.jpg Edgar Link pending
a4indpatientdata.jpg Edgar Link pending
a5table.jpg Edgar Link pending
a6plasmasalivaconcentrati.jpg Edgar Link pending
a7bloodpressure.jpg Edgar Link pending
a8clonidineinhibits.jpg Edgar Link pending
a9cardiaccontractility.jpg Edgar Link pending
exhibit21-1.htm Edgar Link pending
exhibit23-1.htm Edgar Link pending
exhibit31-1.htm Edgar Link pending
exhibit31-2.htm Edgar Link pending
exhibit32-1.htm Edgar Link pending
exhibit4-1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
mono-20201231.xml Edgar Link completed
mono-20201231.xsd Edgar Link pending
mono-20201231_cal.xml Edgar Link unprocessable
mono-20201231_def.xml Edgar Link unprocessable
mono-20201231_lab.xml Edgar Link unprocessable
mono-20201231_pre.xml Edgar Link unprocessable
prxconsulting2020agreemen.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending